Delivery Order SPE2DB22D1106-SPE2DB25FEUD8
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,169.30 by the Defense Logistics Agency on May 29, 2025, for the supply of Risperidone 0.5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of May 30, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement requirements...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for 500 tablets of Risperidone 2 mg at a ceiling value of $3,458. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on August 18, 2025, with a ceiling value of $1,753.78 and firm fixed pricing. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in...
- The Defense Logistics Agency awarded a $12,175.63 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract includes performance through September 11, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract carries no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Risperidone 3 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,237.70. This non-set-aside award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUD8Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on June 18, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units. This firm fixed-price contract, valued at $2,656.71, represents a non-competitive, non-set-aside award with an ultimate completion date of June 20, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product delivery supports the Defense Logistics Agency's Medical Supply Chain, which provides critical medications and medical supplies to military healthcare systems, the Defense Health Agency, and other federal healthcare customers. AmerisourceBergen's comprehensive IDC vehicle enables the company to furnish a broad range of pharmaceutical products, including generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The award of this delivery order demonstrates the contractor's continued capability to fulfill federal pharmaceutical procurement requirements through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/18/25 |